Celera Genomics

Celera Genomics

Infobox_Company
company_name = Celera Group
company_
company_type = Public (NASDAQ|CRA)
slogan =
foundation = 1998
location = Rockville, Maryland
key_people = Tony L. White, CEO & Chairman;Kathy P Ordonez, President
num_employees = 540
industry = Technology
products = Scientific & Technical Instruments
owner =
revenue =
homepage = [http://www.celera.com www.celera.com] |

Celera Genomics (NASDAQ|CRA) was formerly a business unit of the Applera Corporation, but was spun off in July 2008 to become an independent publicly traded company. Celera focuses on genetic sequencing and related technologies. Headquartered in Rockville, Maryland, it was established in May 1998 by the Perkin-Elmer Corporation (and was later purchased by Applera), with Dr. J. Craig Venter from The Institute for Genomic Research (TIGR) as its first president. While at TIGR, Venter and Hamilton Smith led the first successful effort to sequence an entire organism's genome, that of the "Haemophilus influenzae" bacterium. Celera was formed for the purpose of generating and commercializing genomic information to accelerate the understanding of biological processes. Its stock is a tracking stock of Applera, along with the tracking stock of Applera's larger Applied Biosystems Group business unit.

Celera Genomics researchers were among the first to show the feasibility of the whole genome shotgun strategy for sequencing large eukaryotic genomes. The strategy was already in widespread use for smaller prokaryotic genomes, which include bacteria and archaea. This strategy contrasted with the publicly funded Human Genome Project, which used a slower but safer clone by clone sequencing strategy. Celera sequenced the human genome at a fraction of the cost of the public project (approximately $3 billion of taxpayer dollars versus about $300 million of private funding). However, it must be noted that a significant portion of the human genome had already been sequenced when Celera entered the field and thus Celera did not incur any costs with obtaining the existing data, which was freely available to the public from GenBank. Celera's use of the shotgun strategy spurred the public HGP to change its own strategy, leading to a rapid acceleration of the public effort.

Critics of initial efforts by Celera Genomics to hold back data from sections of genome they sequenced for commercial exploitation felt that it would retard progress in science as a whole. These critics pointed to the open access policy for gene sequences from the publicly funded Human Genome Project. Later, the company changed their policy and made their sequences available for non-commercial use, but set a maximum threshold for amount of sequence data a researcher could download at any given time.

The rise and fall of Celera as an ambitious competitor of the Human Genome Project is the main subject of the book The Genome War by James Shreeve, who takes a strong pro-Venter point of view. (He followed Venter around for two years in the process of writing the book.) A view from the public effort's side is that of Nobel laureate Sir John Sulston in his book "The Common Thread: A Story of Science, Politics, Ethics and the Human Genome".

Genomes sequenced by Celera Genomics

Eukaryotes:
*Drosophila melanogaster (fruit fly)
*Human genome
*Mouse genome
*Elephant genome
*Three-toed Sloth genome

External links

* [http://www.celera.com/ Celera Genomics website]
* [http://clinton4.nara.gov/WH/EOP/OSTP/html/00626_4.html Prepared Statement of Craig Venter of Celera] Venter discusses Celera's progress in deciphering the human genome sequence and its relationship to healthcare and to the federally funded Human Genome Project.
* [http://www.applera.com/ Applera Corporation website]
* [http://www.genome.gov/ U.S. National Institutes of Health website for the Human Genome Research Institute]


Wikimedia Foundation. 2010.

Игры ⚽ Поможем написать реферат

Look at other dictionaries:

  • Celera Genomics — ist eine US amerikanische Firma, die im Mai 1998 von der PE Corporation (heute Applera Corporation) und Craig Venter, einem Genomforscher und Gründer des Institute for Genomic Research (TIGR), gegründet wurde. Der Name Celera leitet sich von… …   Deutsch Wikipedia

  • Celera Genomics — est une entreprise fondée en mai 1998 par PE Corporation (maintenant Applera Corporation) et Craig Venter. Celera fut créée dans le but de générer puis commercialiser des informations génétiques afin d accélerer la compréhension des processus… …   Wikipédia en Français

  • Celera Genomics — Saltar a navegación, búsqueda Celera Genomics es el nombre de una empresa estadounidense fundada en mayo de 1998 por Applera Corporation y J. Craig Venter, con el objetivo primario de secuenciar y ensamblar el genoma humano en plazo de tres años …   Wikipedia Español

  • Celera Genomics — es el nombre de una empresa estadounidense fundada en mayo de 1998 por Applera Corporation y J. Craig Venter, con el objetivo primario de secuenciar y ensamblar el genoma humano en tres años …   Enciclopedia Universal

  • Celera Genomics Corporation — Celera Genomics ist eine US amerikanische Firma, die im Mai 1998 von der PE Corporation (heute Applera Corporation) und Craig Venter, einem Genomforscher und Gründer des Institute for Genomic Research (TIGR), gegründet wurde. Der Name Celera… …   Deutsch Wikipedia

  • Celera — Corporation Rechtsform Corporation ISIN US15100E1064 Gründung Mai 1998 Sitz Alameda, USA Leitung Kathy Ordoñez …   Deutsch Wikipedia

  • Synthetic Genomics — Synthetic Genomics  американская компания, разрабатывающая технологии использования модифицированных или синтетически произведённых микроорганизмов для производства альтернативных видов топлива  этанола и биоводорода. Одним из… …   Википедия

  • Synthetic Genomics — is a company dedicated to using modified or synthetically produced microorganisms to produce the alternative fuels ethanol and hydrogen. Synthetic Genomics was founded in part by J. Craig Venter. Venter s previous company, Celera Genomics, was a… …   Wikipedia

  • Applied Biosystems — Applied Biosystems, Inc. (formerly nasdaq2|ABIO) is the original name of a pioneer biotechnology company founded in 1981 in Foster City, California, in the San Francisco Bay Area. [http://marketing.appliedbiosystems.com/mk/get/25YRSEMS HERRITAGE… …   Wikipedia

  • Human Genome Project — The Human Genome Project (HGP) was an international scientific research project with a primary goal to determine the sequence of chemical base pairs which make up DNA and to identify the approximately 25,000 genes of the human genome from both a… …   Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”